Pouliot F, Lodde M, Besançon M, Castonguay V, Morin-Coulombe A, Fradet V, et al. Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases treated in a single Canadian center. CUAJ [Internet]. 2026 Feb. 13 [cited 2026 Apr. 30];20(6). Available from: https://cuaj.ca/index.php/journal/article/view/9398